BioOutsource Ltd. has opened a new Biosimilar Centre of Excellence in Glasgow, doubling its capacity for the analysis of biosimilar monoclonal antibodies. The new CoE is adjacent to the company’s existing BioOutsource facility on the West of Scotland Science Park, and will employ approximately 40 lab and R&D scientists.   “The global biosimilar market is predicted to more than double in size to $19 billion by 2018. The increasing demand for our biosimilars services and the addition of severa...